Ameriprise’s Sagimet Biosciences SGMT Stock Holding History
Bought
Maintained
Sold
Other funds holding SGMT
SVCM
Ameriprise's SGMT Position: Q3 2026 in Review
Ameriprise increased its Sagimet Biosciences (SGMT) stake by 227% in Q3 2026, buying an estimated $12.1M and bringing the position to 1,900,603 shares worth $18.8M. The position accounts for ﹤0.01% of the portfolio, ranked #1546.
Ameriprise first reported a position in SGMT in Q2 2026 and has held it in 2 quarters since. 129 funds tracked by Wall St. Rank hold SGMT as of Q3 2026.
- Ameriprise held 1,900,603 shares of Sagimet Biosciences worth $18.8M as of Q3 2026.
- Ameriprise bought 1,319,386 Sagimet Biosciences shares in Q3 2026, an estimated $12.1M.
- Sagimet Biosciences made up ﹤0.01% of Ameriprise's portfolio in Q3 2026, its #1546 holding.
- Ameriprise first reported a position in Sagimet Biosciences in Q2 2026 and has held it in 2 quarters since.
- 129 funds tracked by Wall St. Rank held Sagimet Biosciences as of Q3 2026.
Based on Ameriprise's 13F filing for Q3 2026, filed 16 Nov 2026.